Ondansetron as a Supportive Therapeutic Agent for Severe Pruritus in Pediatric Patients with Chronic Cholestasis

Indian J Pediatr. 2024 Jan;91(1):92. doi: 10.1007/s12098-023-04755-x. Epub 2023 Jul 17.

Authors

Nehal M El-Koofy¹, Mohamed A Elmonem², Mai El-Mahdy¹, Sawsan Okasha¹, Afaf Enayet¹

Affiliations

¹ Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
² Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt. mohamed.abdelmonem@kasralainy.edu.eg.

PMID: 37458976
DOI: 10.1007/s12098-023-04755-x

No abstract available

Publication types

Letter

MeSH terms

Child
Cholestasis* / complications
Cholestasis* / drug therapy
Humans
Ondansetron* / therapeutic use
Pruritus / drug therapy
Pruritus / etiology

Substances

Ondansetron